Journal profile · Immunology
Transfusion Clinique et Biologique
ISSN 1246-7820 · eISSN 1953-8022 · Elsevier Masson · FRANCE · Bimonthly · Founded 1994
Transfusion Clinique et Biologique: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.24; hybrid open access; APC about USD 1,820; review about 34 days (submission to acceptance, publisher); community-reported acceptance: easy (Elsevier website: 53%); 442 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Transfusion Clinique et Biologique is published by Elsevier Masson and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Blood donation and transfusion practices, Blood groups and transfusion and Blood transfusion and management, together about 47.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Transfusion Clinique et Biologique, the official journal of the French-Speaking Society of Blood Transfusion (SFTS):is an aid to training, at a European level,is the only French journal indexed in the hematology and immunology sections of Current Contents.The journal welcomes original articles, reviews, editorials, opinion articles, perspectives, commentaries and letters to the editors. Clinical cases are no longer accepted unless previously discussed with the editor-in-chief. Transfusion Clinique et Biologique is published 4 times a year (supplements can be considered). The main topics covered by the journal are: clinical transfusion, blood donation, hemovigilance, blood component processing, patient blood management, transfusion organization and management, quality management, immunohematology and genetics of blood groups, molecular biology and transfusion transmitted infections, etc. The journal also welcomes cell and tissue collection, processing, quality and safety, therapy and vigilance. Topics outside the main coverage must be previously discussed with the editor-in-chief. Readership is wide, both in terms of scientific and medical specialties and geographic origin. Thus, it is recommended that all contributions consider this type of audience. Contributions should bring novelty to others, in a different medical specialty or in another country. Transfusion clinique et biologique, journal officiel de la Société Francophone de Transfusion Sanguine (SFTS) est :un outil de formation au rayonnement européen,la seule revue française indexée aux Current Contents dans les sections hématologie et immunologie.La revue accepte les articles originaux, les revues, les éditoriaux, les articles d'opinion, les perspectives, les commentaires et les lettres à la rédaction. Les cas cliniques ne sont plus acceptés, sauf s'ils ont été préalablement discutés avec le rédacteur en chef. Transfusion Clinique et Biologique est publiée 4 fois par an (des suppléments peuvent être envisagés). Les principaux thèmes abordés par la revue sont les suivants : transfusion clinique, don de sang, hémovigilance, traitement des composants sanguins, gestion du sang des patients, organisation et gestion des transfusions, gestion de la qualité, immuno-hématologie et génétique des groupes sanguins, biologie moléculaire et infections transmissibles par transfusion, etc. La revue accepte également les articles sur le prélèvement, le traitement, la qualité et la sécurité des cellules et des tissus, ainsi que sur les thérapies et la vigilance. Les thèmes qui ne font pas partie des principaux domaines couverts doivent être préalablement discutés avec le rédacteur en chef. Le lectorat est large, tant en termes de spécialités scientifiques et médicales que d'origine géographique. Il est donc recommandé que toutes les contributions tiennent compte de ce type de public. Les contributions doivent apporter une nouveauté à d'autres, dans une spécialité médicale différente ou dans un autre pays.
From the journal's Aims & Scope
Research area (LetPub): Immunology
Editor-in-chief Olivier GarraudPublisher website
Editorial board by country: none in mainland China; most named France 23, Netherlands 5, Brazil 4, United States 2, India 2 (45 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood donation and transfusion practicesBusiness, Management and Accounting21.6%
- Blood groups and transfusionMedicine13.6%
- Blood transfusion and managementMedicine12.4%
- Health, Medicine and SocietyHealth Professions7%
- Hemoglobinopathies and Related DisordersMedicine6.2%
- Healthcare Systems and PracticesHealth Professions6%
- Trauma, Hemostasis, Coagulopathy, ResuscitationMedicine5%
- Hepatitis B Virus StudiesMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedCurrent ContentsPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.24LetPub ·
- Impact factor (publisher)
- 1.3Publisher website ·
- CiteScore 2026-06
- 2.2LetPub ·
- CiteScore (publisher)
- 2.2Publisher website ·
- SJR 2026-06
- 0.34LetPub ·
- SNIP 2026-06
- 0.78LetPub ·
- h-index
- 36LetPub ·
- h-index
- 53OpenAlex ·
- i10-index
- 496OpenAlex ·
- 2-year mean citedness
- 0.38OpenAlex ·
- Self-citation rate
- 7.7%LetPub ·
- Share of gold OA articles
- 9.93%LetPub ·
Volume
- Articles per year
- 42LetPub ·
Articles by year OpenAlex count · 6,297 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 72 | 8 | 14 |
| 2025 | 442 | 15 | 78 |
| 2024 | 69 | 19 | 130 |
| 2023 | 448 | 24 | 185 |
| 2022 | 230 | 30 | 314 |
| 2021 | 424 | 79 | 553 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed
Not usableThis publisher's "received" date is mostly when the revised manuscript arrived (31% of articles were "accepted" within 3 days), so it cannot measure review time
Figures by source
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- 53%LetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- First decision after review
- 53 daysPublisher website ·
- Submission to acceptance
- 34 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 1,820 / EUR 1,660 / GBP 1,460 / JPY 225,730 | — | — | |
| Publisher website | USD 2,280 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Suggested reviewers
- Required
- Highlights
- Required
- Graphical abstract
- Optional
Article types accepted12
- concise reportsThose articles have the same rules as original articles except length.Length not stated
- correspondenceCorrespondence is either a commentary about a publication that has been released by this Journal or incidentally by another Journal (after Editors’ advice), or …Length not stated
- editorialBefore submitting an article to Transfusion Clinique et Biologique, authors are welcome to check the following issues:Does the topic of the article fall within …Length not stated
- letter to the editorBefore submitting an article to Transfusion Clinique et Biologique, authors are welcome to check the following issues:Does the topic of the article fall within …Length not stated
- opinionBefore submitting an article to Transfusion Clinique et Biologique, authors are welcome to check the following issues:Does the topic of the article fall within …Length not stated
- original articleBefore submitting an article to Transfusion Clinique et Biologique, authors are welcome to check the following issues:Does the topic of the article fall within …Length not stated
- original articlesOriginal articles report new and original work that has not been published elsewhere (except as an abstract at a conference).Length not stated
- perspectiveBefore submitting an article to Transfusion Clinique et Biologique, authors are welcome to check the following issues:Does the topic of the article fall within …Length not stated
- protocolBefore submitting an article to Transfusion Clinique et Biologique, authors are welcome to check the following issues:Does the topic of the article fall within …Length not stated
- recommendations and meta-analysisThe journal encourages the publication of recommendations, after a pre-submission inquiry if appropriate.Length not stated
- reviewBefore submitting an article to Transfusion Clinique et Biologique, authors are welcome to check the following issues:Does the topic of the article fall within …Length not stated
- review articlesReview articles either provide a comprehensive discussion of available knowledge or an update of recent data about a specific topic.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Author contributions
For transparency, we encourage corresponding authors to provide co-author contributions to the manuscript using the relevant CRediT roles. The CRediT taxonomy includes 14 different roles describing each contributor's specific contribution to the scholarly output. The roles are: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administratio…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Ethics form required Model summary
All authors are expected to supply, alongside their article and other files, a single completed ethics form which includes all requested declarations (see below) and can be downloaded here.
Source ↗Publisher website ·- License & copyright Copyright
Journal Publishing Agreement Model summary
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page from the Journal Homepage for more information.
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…
Source ↗Publisher website ·- Preprints Preprints
Preprints can be shared anywhere at any time Model summary
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see Multiple, redundant or concurrent publication for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Masson
- Country or region
- FRANCE
- Language
- Multi-Language
- Frequency
- Bimonthly
- Founded
- 1994
- ISSN
- 1246-7820
- Electronic ISSN
- 1953-8022
- Society / sponsor
- French-Speaking Society of Blood Transfusion
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Transfusion Clinique et Biologique
What CAS zone is Transfusion Clinique et Biologique in?
In the 2025 upgraded edition of the CAS Journal Ranking, Transfusion Clinique et Biologique is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology / Immunology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Transfusion Clinique et Biologique?
The latest impact factor listed by LetPub is 1.24; CiteScore 2.2, h-index 53.
How long does peer review take at Transfusion Clinique et Biologique?
The publisher reports about 34 days (submission to acceptance); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy (Elsevier website: 53%)”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Transfusion Clinique et Biologique?
According to the journal's author guidelines: Suggested reviewers: Required; Highlights: Required; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Transfusion Clinique et Biologique based?
Of the 45 board members whose country the journal's board page names, none are in mainland China; the countries named most often are France (23), Netherlands (5) and Brazil (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Transfusion Clinique et Biologique?
According to LetPub and DOAJ records, Transfusion Clinique et Biologique is indexed in SCIE and Scopus. The journal's website also lists PubMed and Current Contents; that list has not been checked against each database.
Is Transfusion Clinique et Biologique open access, and what is the APC?
Transfusion Clinique et Biologique is a hybrid journal. For open-access publication: APC about USD 1,820.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .